Sexually Transmitted Disease (STD) Diagnosis Market to Reach $12,854.3 Million in 2035, Growing at 7.3% CAGR

Sexually transmitted disease (STD) diagnosis market valued at $6,403.2 million in 2025 and is projected to reach $12,854.3 million by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The market encompasses diagnostic solutions used for the detection and screening of sexually transmitted infections across diverse healthcare settings. The market is witnessing steady global growth driven by the rising prevalence of sexually transmitted infections, increasing awareness regarding early diagnosis, and expanding access to screening programs. Growth is further supported by government-led testing initiatives, integration of rapid diagnostic technologies, and rising demand for point-of-care testing solutions that enable faster results and improved patient management. Advancements in molecular diagnostics, nucleic acid amplification tests (NAATs), and multiplex testing platforms are significantly enhancing detection accuracy and turnaround time, thereby strengthening market expansion.

Browse the full report description of “Sexually Transmitted Disease (STD) Diagnosis Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus and Others), By Product (Laboratory Testing Devices and Point-Of-Care Testing Devices), By End-User (Hospitals and Clinics, Diagnostic Centers and Homecare) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size

According to data from global health organizations such as the World Health Organization, the increasing burden of sexually transmitted infections and the need for early detection have significantly driven the adoption of advanced diagnostic solutions. Large-scale screening programs, surveillance systems, and global health initiatives are playing a critical role in strengthening testing infrastructure, improving disease monitoring, and ensuring timely treatment across regions.

Key Statistics: Sexually Transmitted Disease (STD) Diagnosis at a Glance

• The World Health Organization estimates over 1 million new sexually transmitted infections are acquired every day globally.
• More than 374 million new infections of chlamydia, gonorrhea, syphilis, and trichomoniasis occur annually globally.
• Human papilloma virus (HPV) is responsible for nearly 95% of cervical cancer cases, reinforcing the importance of widespread screening and diagnostic testing.

Key Innovators Driving Sexually Transmitted Disease (STD) Diagnosis Transformation

The key players in the sexually transmitted disease (STD) diagnosis market include Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Hologic, Inc., QIAGEN N.V, among others.

• In July 2025, Abbott Laboratories introduced an advanced molecular diagnostic assay for rapid detection of multiple sexually transmitted infections, enhancing laboratory efficiency and diagnostic accuracy.
• In May 2025, Hologic, Inc. expanded its Panther system capabilities with new assays for chlamydia and gonorrhea testing, aimed at improving high-throughput screening and workflow automation in clinical laboratories.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Disease Type
  • By Product
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Hologic, Inc., QIAGEN N.V, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Sexually Transmitted Disease (STD) Diagnosis Market Report Segment

By Disease Type

• Chlamydia
• Syphilis
• Gonorrhea
• Herpes Simplex Virus
• Human Papilloma Virus
• Human Immunodeficiency Virus
• Others

By Product

• Laboratory Testing Devices
• Point-Of-Care Testing Devices

By End-User

• Hospitals and Clinics
• Diagnostic Centers
• Homecare

Global Sexually Transmitted Disease (STD) Diagnosis Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sexually-transmitted-disease-market-size